SUBSCRIBE NOW
Free Newsletter
India and the European Union have reportedly hit a snag in their long-running negotiations over a free trade agreement, hoped to boost bilateral trade by nearly $30 billion. Initially slated for signature in early April, the agreement now appears to have been postponed until 2012. One of the key sticking points in the negotiations is a proposal to enhance intellectual property protections for medicine. India has a thriving generic drug industry. It did not allow patents on pharmaceutical products until 2005, when it adapted its laws to conform with the World Trade Organization’s intellectual property rules. Products produced prior to […]